LFLYW:NSD-Leafly Holdings Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 0.022

Change

0.00 (-5.58)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-03 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
WBA Walgreens Boots Alliance Inc

N/A

USD 8.20B
HITI High Tide Inc

N/A

USD 0.26B
PETS PetMed Express Inc

N/A

USD 0.10B
CJJD China Jo-Jo Drugstores Inc

N/A

USD 0.01B
MDVLQ MedAvail Holdings Inc

N/A

N/A
SCNX Scienture Holdings, Inc.

N/A

N/A

ETFs Containing LFLYW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.91% 100% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.91% 100% F 96% N/A
Trailing 12 Months  
Capital Gain 26.44% 80% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.44% 80% B- 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -32.10% 40% F 6% D-
Dividend Return -32.10% 20% F 6% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 44.88% 60% D- 42% F
Risk Adjusted Return -71.53% 40% F 9% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector